RCAN1, also known as DSCR1, is an endogenous regulator of calcineurin, a serine/threonine protein phosphatase that plays a critical role in many physiological processes. In this report, we demonstrate that p38 MAP kinase can phosphorylate RCAN1 at multiple sites in vitro and show that phospho-RCAN1 is a good protein substrate for calcineurin. In addition, we found that unphosphorylated RCAN1 noncompetitively inhibits calcineurin protein phosphatase activity and that the phosphorylation of RCAN1 by p38 MAP kinase decreases the binding affinity of RCAN1 for calcineurin. These findings reveal the molecular mechanism by which p38 MAP kinase regulates the function of RCAN1/calcineurin through phosphorylation. [9] . The most thoroughly characterized calcineurin substrates are the nuclear factor of activated T cells (NFAT) family transcription factors. Two distinct calcineurin docking motifs from NFAT, the PxIxIT and LxVP binding motifs, have been identified [1013]. The PxIxIT motif is proposed to be the main calcineurin binding site, and it is present in many other calcineurin substrates and regulatory proteins. NFAT transcription factors are expressed in most immune cell types and play a central role in the regulation of cytokine gene expression. The localization of NFAT is regulated by its phosphorylation status. Calcineurin dephosphorylates multiple residues within the regulatory domain of NFAT, leading to its nuclear translocation and the activation of target genes including PTGS2 (COX-2) and TNF- (TNFA) [11, 14] .
Calcineurin (CN) is a Ca
2+ /calmodulin-dependent serine/ threonine protein phosphatase with roles in myriad physiological functions [13], including T cell activation [4] , apoptosis [5] , skeletal myocyte differentiation [6] , neuronal synaptic plasticity [7] , memory formation [8] , and cardiac health [9] . The most thoroughly characterized calcineurin substrates are the nuclear factor of activated T cells (NFAT) family transcription factors. Two distinct calcineurin docking motifs from NFAT, the PxIxIT and LxVP binding motifs, have been identified [1013] . The PxIxIT motif is proposed to be the main calcineurin binding site, and it is present in many other calcineurin substrates and regulatory proteins. NFAT transcription factors are expressed in most immune cell types and play a central role in the regulation of cytokine gene expression. The localization of NFAT is regulated by its phosphorylation status. Calcineurin dephosphorylates multiple residues within the regulatory domain of NFAT, leading to its nuclear translocation and the activation of target genes including PTGS2 (COX-2) and TNF- (TNFA) [11, 14] .
The regulation of calcineurin phosphatase activity by cellular inhibitors may have potential as novel modulators for the treatment of calcineurin-related diseases. Several endogenous proteins can inhibit the catalytic activity of calcineurin. Modulatory calcineurin interacting proteins (also called RCAN proteins) are unique among these proteins in terms of their expression pattern, and they function in a negative feedback loop to regulate calcineurin activity. The RCAN proteins comprise a family of endogenous calcineurin regulators that are conserved from yeast to humans and are essential for normal calcineurin signaling. Previous studies have shown that RCAN1 phosphorylation alters its effect on calcineurin. Human RCAN1 is encoded within the Down syndrome critical region on chromosome 21. It is abundantly expressed in the heart, brain, and muscles, and it is overexpressed in the brains of individuals with Down syndrome and Alzheimer's disease [15, 16] . Recently, RCAN1 has been highlighted because of its possible functional link with vertebrate embryonic development and tumor progression [1719] .
In the present study, we demonstrate for the first time that p38 MAP kinase directly phosphorylates RCAN1 at five sites (S93, S108, S112, T124 and T153) in vitro. We conducted kinetic studies on the phospho-RCAN1 protein and demonstrated that it is a good substrate for calcineurin. We further show that the phosphorylation of RCAN1 by p38 MAP kinase decreases its binding affinity for calcineurin, suggesting that phosphorylation may relieve the inhibition of calcineurin signaling by RCAN1.
Materials and methods

Materials
Tris, bacterial purine nucleotide phosphorylase, the materials used to generate the purine nucleotide phosphorylase substrate 7-methyl-6-thioguanosine (MESG), CaCl 2 , and MnCl 2 were purchased from Sigma (St. Louis, MO). 3-(Nmorpholino) propanesulfonic acid (MOPS), bovine serum albumin (BSA), dithiothreitol (DTT), and NaCl were obtained from Amresco (Solon, OH). MESG was synthesized as described previously [20] .
1.2 Plasmid construction and the expression and purification of mouse calcineurin α, RCAN1, p38α MAP kinase, calmodulin (CaM) and p-inhibitor-1
Mouse CNAα and CNB1 were cloned into pET-21b vectors (Novagen) with a C-terminal His 6 -tag and a chloromycetin-resistant pACYCDuet vector, respectively. The two plasmids encoding CNAα and CNB1 were co-transformed into BL21 (DE3) competent cells to express a mouse CNα heterodimer (mCNα). cDNA encoding mouse RCAN1 was kindly provided by Dr. Beverly Rothermel (University of Texas, Southwestern Medical Center, Dallas, TX, USA), and cloned into a pGEX6P1 expression vector with a C-terminal His 6 -tag. RCAN1 mutants were constructed using QuikChange site-directed mutagenesis with the pGEX6P1-RCAN1 plasmid as a template. Mouse CaM was cloned into a modified pGEX4T-2 vector containing an N-terminal GST-tag and a PreScission protease cleavage site. The expression and purification of bisphosphorylated p38α MAP kinase were described previously [21] . Phosphorylated inhibitor-1 was obtained by co-expressing His 6 -tagged human inhibitor-1 (1-171) plasmid with non-tagged mouse PKAc. Each protein was expressed at 25C and initially purified by Ni-NTA (Qiagen) or glutathioneSepharose (GE Healthcare) affinity columns, followed by anion exchange and gel filtration chromatography (Source-15Q and Superdex-200, GE Healthcare). The affinity tag was proteolytically removed from the fusion proteins as indicated. Protein stocks for kinetic analysis were supplemented with glycerol at a final concentration of 20% (v/v). Protein concentrations were determined based on the theoretical molar extinction coefficients at 280 nm.
In vitro phosphorylation of wildtype (WT) and mutant RCAN1
The C-terminally His 6 The GST tags were digested with PreScission protease overnight at 4°C. Gel filtration chromatography (Superdex-200, GE Healthcare) was performed to further purify the phosphorylated RCAN1.
In-gel digestion for mass spectrometry
To identify phosphorylation sites on p-RCAN1 WT and S108A/S112A, samples were separated by SDS-PAGE. The gel bands corresponding to the targeted proteins were excised from the gel, reduced with 25 mmol L 1 DTT and alkylated with 55 mmol L 1 iodoacetamide. Then, in-gel digestion was performed with sequencing grade modified trypsin (Promega, Fitchburg, WI) in 50 mmol L 1 ammonium bicarbonate at 37C overnight. The peptides were extracted twice with 1% trifluoroacetic acid in 50% acetonitrile aqueous solution for 30 min. The extraction mixtures were then concentrated by SpeedVac.
Liquid chromatography-mass spectrometry (LC-MS)/ MS analysis
For LC-MS/MS analysis, the digestion product was separated by a 65 min gradient elution at a flow rate of 0.250 µL min 1 with the EASY-nLCII™ integrated nano-HPLC system (Proxeon, Denmark), which has a direct interface with the Thermo LTQ-Orbitrap mass spectrometer. The analyti-cal column was a homemade fused silica capillary column (75 µm ID, 150 mm length; Upchurch, Oak Harbor, WA) packed with C-18 resin (300 Å, 5 µm, Varian, Lexington, MA). Mobile phase A consisted of 0.1% formic acid, and mobile phase B consisted of 100% acetonitrile and 0.1% formic acid. The LTQ-Orbitrap mass spectrometer was operated in data-dependent acquisition mode using the Xcalibur 2.0.7 software. A single full-scan mass spectrum was conducted in the Orbitrap (400-1800 m/z, 30000 resolution), followed by 20 data-dependent MS/MS scans in the ion trap at 35% normalized collision energy (CID) or 3 MS/MS scans in the quadrupole collision cell with higher energy collision dissociation (HCD). MS/MS spectra from each LC-MS/MS run were searched against the selected database using an in-house Mascot or Proteome Discovery search algorithm.
Calcineurin phosphatase assay
All experiments were performed at 25°C in 1.8 mL reaction mixtures, and the time courses of absorbance changes were recorded using a Lambda 14 Perkin-Elmer spectrophotometer equipped with a magnetic stirrer in the cuvette holder. Initial rates were determined from the linear slope of the progress curves obtained, and the experimental data were analyzed using a nonlinear regression analysis program. Phosphatase activity against p-RCAN1 and p-inhibitor-1 was detected by a continuous spectrophotometric assay. In this coupled system [22] , the phosphate was transferred from p-RCAN1 or p-inhibitor-1 to 7-methyl-6-thioguanosine (MESG) by purine nucleoside phosphorylase. The reaction mixture contained 50 mmol L 1 MOPS pH 7.0, 100
DTT, and a range of concentrations of phospho-protein substrates, 10 μmol L 1 of CaM was added to the p-RCAN1 assay and 1 μmol L 1 CaM was added to the p-inhibitor-1 assay. Dephosphorylation was detected by monitoring the absorbance change at 360 nm caused by the conversion of MESG to 7-methyl-6-thioguanine in the presence of inorganic phosphate. The quantitation of the phosphate release in the dephosphorylation reaction was thus determined using the extinction coefficient of 11200
at 360 nm [23] .
Results
RCAN1 noncompetitively inhibits calcineurin phosphatase activity
RCANs represent a new class of endogenous calcineurin inhibitors [24, 25] . RCAN1 may competitively inhibit the calcineurin-NFAT pathway in vivo because RCAN1 and NFATs share an SP repeat motif and a PxIxIT motif. Recently, Chan et al. [26] demonstrated an inhibitory effect of human RCAN1 on calcineurin that competitively inhibited calcineurin activity against para-Nitrophenylphosphate (pNPP) substrate, a chromogenic compound. pNPP is a small-molecule substrate, and interference with this substrate strongly suggests a direct interaction between RCAN1 and the enzyme active site. To further examine whether the competitive inhibition is unique to small molecule aryl phosphates, we used a protein substrate, phospho-inhibitor-1, to evaluate the inhibitory properties of RCAN1 against calcineurin. Protein phosphatase inhibitor-1 is a prototypical mediator of cross talk between protein kinases and protein phosphatases. The activation of cAMP-dependent protein kinase results in the phosphorylation of inhibitor-1 at Thr-35, converting it to a protein substrate for calcineurin. For inhibition studies, the phospho-inhibitor-1 concentration was constant at 3.3 mol L 1 , and the RCAN1 concentration was varied. The dephosphorylation of phospho-inhibitor-1 was measured using a continuous inorganic phosphate assay in which the P i produced by calcineurin is captured by purine ribonucleoside phosphorylase in the presence of a purine ribonucleoside substrate [22] . Figure 1 shows the effects of RCAN1 on the dephosphorylation of inhibitor-1 by calcineurin. A dose-response curve based on increasing concentrations of RCAN1 demonstrated that RCAN1 inhibited calcineurin activity (inset of Figure 1) . However, the enzymatic activity decreased with an increase in the concentration of RCAN1 and approached a non-zero constant, indicating that binding of RCAN1 only partially inhibited calcineurin phosphatase activity against phospho-inhibitor-1. The apparent dissociation constant, K i , for the calcineurin inhibition reaction was (0.420.01) mol L
1
. 
RCAN1 is phosphorylated by p38α MAP kinase at multiple residues
A previous study identified two S residues in human RCAN1, S108 and S112, as substrates of glycogen synthase kinase 3β (GSK-3β) and ERK2 MAP kinase, respectively [27] . These residues lie within the highly conserved FLISPPxSPP signature motif of the RCAN family. To investigate whether p38 MAP kinase could also phosphorylate RCAN1, in vitro kinase reactions were performed with either WT or mutant (S108A, S112A or S108A/S112A) recombinant RCAN1 proteins and recombinant activated p38 MAP kinase in a kinase assay buffer containing ATP and Mg 2+ , and the electrophoretic mobility of RCAN1 was determined by SDS-PAGE (Figure 2) . At the appropriate time points, aliquots of the reaction mixture were withdrawn, and the reaction was terminated with an equal volume of 2× Laemmli SDS sample buffer, followed by separation on a 15% SDS-PAGE gel. As shown in Figure 2B , RCAN1 exhibited a time-dependent change in phosphorylation, as indicated by the electrophoretic mobility shift. The p38 MAP kinase-catalyzed phosphorylation was nearly 100% complete at 30 min, and the fully phosphorylated RCAN1 protein ran as a single band on a 15% SDS-PAGE gel.
To identify specific RCAN1 residues that were phosphorylated by p38α MAP kinase, we purified the p38α MAP kinase-phosphorylated RCAN1 WT and RCAN1 S108A/S112A proteins and performed electrospray mass spectrometry. As shown in Figure 3 and Figure 4 , electrospray spectrometry of a tryptic digestion of phospho-RCAN1 revealed five phosphorylation sites in WT RCAN1 (S93, S108, S112, T124 and T153) ( Figure 3 ) and three sites in RCAN1 S108A/S112A (S93, T124 and T153) (Figure 4 ).
p38α MAP kinase-phosphorylated RCAN1 is a good substrate for calcineurin
We next determined whether p38α MAP kinase-phosphorylated RCAN1 could serve as a calcineurin substrate using a continuous spectrophotometric assay. In this method, the phosphorylation level of RCAN1 was measured by the amount of inorganic phosphate released from RCAN1 after treatment with calcineurin. The inorganic phosphate produced was monitored continuously by a coupled enzyme assay using purine nucleoside phosphorylase and its chromophoric substrate, MESG, and quantitated using the extinction coefficient of 11200 M 1 cm 1 at 360 nm. Figure 5A shows time courses for the dephosphorylation of phospho-RCAN1 by calcineurin. The data in this figure show that the calcineurin-catalyzed reaction was nearly 100% complete in 15 min. When all of the substrate had been converted to product, the phosphorylation stoichiometry of RCAN1 was determined to be close to 5 mol phosphate/mol RCAN1. As expected, only 3 equivalents of inorganic phosphate were released upon treatment of the S108A/ S112A mutant with calcineurin. These results further support our conclusion that p38α MAP kinase can phosphorylate RCAN1 at multiple residues in vitro.
To further characterize the biochemical properties of phospho-RCAN1, we measured the kinetic parameters of the calcineurin-catalyzed reaction using phosphorylated RCAN1 and the S108A/S112A mutant as substrates. All steady-state kinetic studies were performed at pH 7.0 and 25°C. The initial rates of the dephosphorylation reaction were determined from the slopes of the initial linear portion of the progress curves. Figure 5B shows the initial rates of the calcineurin-catalyzed reaction at different RCAN1 concentrations. Because the concentrations of RCAN1 and calcineurin were comparable in the reaction, the assumption that the free substrate concentration was equal to the total substrate concentration could not be made. Thus, the kinetic data were analyzed using the general initial velocity equation, taking substrate depletion into account. corresponding to the mass of the mono-phosphorylated peptide LYFAQTLHIGSSHLAPPNPDK. A loss of 98 Da (H 3 PO 4 ) was observed for the precursor ion under the higher energy collision dissociation (HCD). The labeled peaks correspond to the masses of the y and b ions of the modified peptides. The y10 ion was observed to have high intensity compared to the phosphorylated y10 ion, as shown in the inserted figure, suggesting that Ser-11 is the major phosphorylated residue. B, The MS/MS spectrum of a triply charged ion at m/z 595.61 for MH 3 3+ corresponding to the mass of the di-phosphorylated peptide QFLISPPASPPVGWK. The labeled peaks correspond to the masses of the b and y ions of the di-phosphorylated peptide, indicating that both Ser residues are phosphorylated. C, The MS/MS spectrum of a triply charged ion at m/z 739.36 for MH 3 3+ corresponding to the mass of the mono-phosphorylated peptide qVEDATPVINYDLLYAISK (in which the first residue Gln is a pyroglutamine). The labeled peaks correspond to the masses of the b and y ions of the mono-phosphorylated peptide, indicating that phosphorylation is on the Thr-6 residue. D, The MS/MS spectrum of a triply charged ion at m/z 1328.55 for MH 3 3+ , corresponding to the mass of a mono-phosphorylated peptide YELHAATDPTPSVVVHVCESDQENEE-EEEEMER in which the Cys was carbamidomethylated and the Met was oxidized. The loss of 98 Da (H 3 PO 4 ) was observed for precursor ions under CID. The labeled peaks correspond to the masses of the b and y ions of the mono-phosphorylated peptide, indicating that phosphorylation is on the Thr-10 residue.
Direct curve fitting of the data to eq. (1) yielded the k cat and K m values for the dephosphorylation of RCAN1 and the S108A/S112A mutant by calcineurin ( Table 1 ). The K m values are approximately 7-fold greater than the inhibition constant K i , indicating that unphosphorylated RCAN1 appeared to bind more strongly to calcineurin than p38 MAP kinase-phosphorylated RCAN1. The substrate specificity constant k cat /K m of RCAN1 was calculated as (0.590.15)  
Discussion
RCANs were first identified using screens for calcineurin binding proteins in fungi [25] . The overexpression of the yeast protein RCN1 or human RCAN1 inhibited at least two independent functions of calcineurin in yeast, the activation of the transcription factor Tcn1p and the inhibition of the H + /Ca 2+ exchanger Vcx1p. Signaling via calmodulin, calcineurin, and Tcn1p induced RCN1 expression, suggesting that RCN1 operates as an endogenous feedback inhibitor of calcineurin [24] . Human RCAN1 proteins are expressed in diverse cell types, including neurons and muscles [2931], and have complex effects in cells. However, the precise mechanisms and detailed roles of RCANs in calcineurin signaling are still unclear.
RCAN1 has been reported to be phosphorylated by various kinases, such as glycogen synthase kinase 3 (GSK-3) [27, 32] , ERK2 MAP kinase [27] , big MAP kinase 1 (BMK1) [33] , NFB-inducing kinase (NIK) [34] , TGF-β-activated kinase 1 (TAK1) [35] , dual specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) [36] and protein kinase A (PKA) [37] . The phosphorylation of RCAN1 has been shown to regulate calcineurin activity both positively and negatively. The central region of RCAN1 contains a perfect match to the GSK-3 consensus phosphorylation site (S108) [27] in the SP repeat of RCAN1. Phosphorylation by Figure 5 Dephosphorylation of RCAN1 WT and S108A/S112A by calcineurin. A, The time courses of p-RCAN1 WT (curve 2) and S108A/ S112A (curve 1) dephosphorylation by calcineurin. B, The dependence of the initial rate of the calcineurin-catalyzed reaction on the concentration of p-RCAN1 WT (open circle) and p-RCAN1 S108A/S112A (solid circle). 1 µmol L 1 calcineurin was used as the phosphatase.
GSK-3 requires a priming phosphorylation at a nearby site (S112) by ERK2 [27] . The GSK-3-mediated phosphorylation of RCAN1 activates calcineurin signaling in vivo [32] . Similarly, TAK1 phosphorylates RCAN1 at two positions, S94 and S136, converting it from an inhibitor to a facilitator of calcineurin-NFAT signaling [35] . BMK1 can phosphorylate RCAN1 at S112, and the BMK1-mediated phosphorylation of RCAN1 promotes the dissociation of RCAN1 from calcineurin, thereby relieving its inhibition of calcineurin activity [33] . In contrast, a recent report showed that Dyrk1A can phosphorylate RCAN1 at S112 and T192, and the phosphorylation of RCAN1 at T192 by Dyrk1A increases its ability to inhibit calcineurin phosphatase activity [36] . The PKA-mediated phosphorylation of RCAN1 at an unknown phosphorylation site has also been shown to enhance its inhibition of calcineurin-mediated gene transcription [37] . In addition to regulating calcineurin activity, the phosphorylation of RCAN1 affects its protein stability through the ubiquitin-proteasome pathway [38] . The phosphorylation of RCAN1 at the FLISPP motif controls the half-life of RCAN1 by accelerating its degradation, while phosphorylation of the C-terminal region by NIK blocks degradation and increases the stability of the protein.
In the present study, we examined the putative role of p38 MAP kinase in the regulation of RCAN1 activity. We found that p38 MAP kinase phosphorylates RCAN1 on multiple sites both within and outside the FLISPP motif in vitro (S93, S108, S112, T124 and T153). Thus, p38 MAP kinase-mediated RCAN1 phosphorylation may represent a previously unrecognized MAP kinase cascade that regulates calcineurin signaling. The physiological significance of the MAP kinase regulation of calcineurin activation through the phosphorylation of RCAN1 will be an interesting topic for future studies.
